Table I.
Clinicopathological characteristics of study groups.
| Group
|
|||
|---|---|---|---|
| Characteristic | CG (n=16) | OG (n=12) | EG (n=11) |
| Histological diagnosis of biopsies | |||
| Atrophic endometrium | 10 | 11 | - |
| Proliferative endometrium | 4 | - | - |
| Secretory endometrium | 2 | 1 | - |
| Endometrioid cancer | - | - | 11 |
| Age of patients (years) | |||
| <50 | 4 | 1 | 2 |
| 50–60 | 6 | 6 | 3 |
| >60 | 6 | 5 | 6 |
| Menopausal status | |||
| Premenopausal | 6 | 1 | 1 |
| Postmenopausal | 10 | 11 | 10 |
| Body mass index | |||
| ≤24.9 | 4 | 3 | - |
| 25.0–29.9 | 10 | 4 | 2 |
| ≥30 | 2 | 5 | 9 |
| TNM stage | |||
| I | - | 4 | 8 |
| II | - | 1 | 1 |
| III | - | 3 | 2 |
| IV | - | 4 | - |
| Histological grade | |||
| G1, well-differentiated | - | 1 | 6 |
| G2, moderately differentiated | - | 5 | 5 |
| G3, poorly differentiated | - | 6 | - |
CG, control group; OG, ovarian cancer group; EG, endometrial cancer group; TNM, tumor-node-metastasis staging system.